|
VTI1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.79720691054308E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.73669975570101E-13 |
| Normal-vs-Stage2 |
7.797600E-02 |
| Normal-vs-Stage3 |
3.40399930465196E-11 |
| Normal-vs-Stage4 |
1.67588165567167E-12 |
| Stage1-vs-Stage2 |
3.382900E-04 |
| Stage1-vs-Stage3 |
8.437400E-01 |
| Stage1-vs-Stage4 |
1.668080E-02 |
| Stage2-vs-Stage3 |
1.246160E-04 |
| Stage2-vs-Stage4 |
1.70659999998435E-06 |
| Stage3-vs-Stage4 |
4.190000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.70814490224802E-14 |
| Normal-vs-AfricanAmerican |
2.3164000000353E-06 |
| Normal-vs-Asian |
3.94419996663231E-09 |
| Caucasian-vs-AfricanAmerican |
6.305800E-01 |
| Caucasian-vs-Asian |
5.790200E-01 |
| AfricanAmerican-vs-Asian |
9.448800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.2263527667028E-12 |
| Normal-vs-Female |
1.7996049095359E-11 |
| Male-vs-Female |
3.988200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63546953757532E-12 |
| Normal-vs-Age(41-60Yrs) |
8.82910411448279E-11 |
| Normal-vs-Age(61-80Yrs) |
7.49190000037814E-08 |
| Normal-vs-Age(81-100Yrs) |
1.53353999999828E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.867830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.882500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.003000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.513000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.182200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.640430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.497800E-02 |
| Classical-VS-Follicular |
4.45870000032045E-07 |
| Classical-VS-Other |
7.100000E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
1.93879999832447E-08 |
| Tall-VS-Other |
7.128200E-01 |
| Tall-VS-Normal |
1.74005254649501E-12 |
| Follicular-VS-Other |
7.010100E-02 |
| Follicular-VS-Normal |
1.555510E-02 |
| Other-VS-Normal |
2.243700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.69219999626813E-08 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
8.30000002061126E-09 |
|
|
